# EIR Pharmaceuticals, LLC — Form D

EIR Pharmaceuticals, LLC of Olathe, KS, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-30. $70K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-08-30
- Form: D
- Accession: 0001786037-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $70K
- Minimum investment: $1
- Investors: 3
- Date of first sale: 2019-08-16
- Revenue range: Decline to Disclose
- SEC file number: 021-347715

## Issuer

- Name: EIR Pharmaceuticals, LLC
- CIK: 0001786037
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 10900 South Clay Blair Boulevard, Olathe, KS, 66061
- Phone: (515) 231-0874

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Skaff | Executive Officer | Olathe, KS |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-09-09](https://search.stillhousedata.com/formd/0001786037-19-000002) | D/A | — | $70K |

## More

- [CIK 1786037 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1786037&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001786037-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.